FDA panel is reviewing if 7 peptides should be made more accessible, an RFK Jr. priority

A Food and Drug Administration committee voted to recommend that certain pharmacies be allowed to produce at least one in a set of controversial peptides, a victory for Health Secretary Robert F. Kennedy Jr.’s efforts to promote peptides despite FDA researchers’ calls for caution.